Lisata Therapeutics Inc (LSTA)

May 01, 2025

Lisata Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update on Thursday, May 8, 2025 - The Manila Times

May 01, 2025

May 01, 2025

Lisata Therapeutics to Report First Quarter 2025 Financial - GlobeNewswire

May 01, 2025

May 01, 2025

Lisata Therapeutics Earnings: Solid Tumor Treatment Developer Reports Q1 2025 Results May 8 - Stock Titan

May 01, 2025

Apr 26, 2025

Will Lisata Therapeutics (NASDAQ:LSTA) Spend Its Cash Wisely? - Yahoo Finance

Apr 26, 2025

Apr 24, 2025

LSTALisata Therapeutics Inc Latest Stock News & Market Updates - Stock Titan

Apr 24, 2025

Apr 22, 2025

Lisata Therapeutics (NASDAQ:LSTA) Shares Up 0.9% – Still a Buy? - Defense World

Apr 22, 2025

Apr 20, 2025

Lisata Therapeutics talks ADC breakthrough with Catalent – ICYMI - Proactive financial news

Apr 20, 2025

Apr 17, 2025

Lisata Therapeutics announces research license with Catalent - MSN

Apr 17, 2025

Apr 16, 2025

Lisata Therapeutics CMO discusses potential for certepetide under Catalant license agreement - Proactive financial news

Apr 16, 2025

Apr 16, 2025

Lisata Therapeutics CMO discusses potential for certepetide under Catalent license agreement - Proactive Investors

Apr 16, 2025

Apr 15, 2025

Market movers: Meta, HPE, Applied Digital, Lisata Therapeutics... - Proactive Investors

Apr 15, 2025

Apr 15, 2025

Lisata Therapeutics (LSTA) Partners with Catalent on Preclinical Study | LSTA Stock News - GuruFocus

Apr 15, 2025

Apr 15, 2025

Lisata Therapeutics Announces Research License with Catalent - GlobeNewswire

Apr 15, 2025

Apr 15, 2025

Lisata Therapeutics, Inc. Announces Research License with Catalent, Inc - marketscreener.com

Apr 15, 2025

Apr 15, 2025

Lisata falls after mid-stage data for anticancer agent - MSN

Apr 15, 2025

Apr 12, 2025

Lisata Therapeutics Wins 2024 BioTech Breakthrough Award for ‘Specialized BioTherapeutics Company of the Year’ - MarketScreener

Apr 12, 2025

Apr 05, 2025

Neostem stock plunges to 52-week low at $2.01 amid market challenges - Investing.com Australia

Apr 05, 2025

Apr 04, 2025

Neostem stock plunges to 52-week low at $2.01 amid market challenges By Investing.com - Investing.com South Africa

Apr 04, 2025

Mar 21, 2025

Healthcare investment strategies reshaped by inflation, interest rates and M&A in 2025 - Proactive financial news

Mar 21, 2025

Mar 18, 2025

Endometriosis Pain Pipeline 2025: FDA Approvals and Clinical - openPR.com

Mar 18, 2025

Mar 08, 2025

Lisata Therapeutics CEO discusses AI drug discovery collaborationICYMI - Proactive Investors

Mar 08, 2025

Mar 07, 2025

Lisata Therapeutics expands drug discovery with GATC AI collaboration - Proactive Investors USA

Mar 07, 2025

Mar 07, 2025

Lisata Therapeutics expands drug discovery with GATC AI collaboration | NASDAQ:LSTA - Proactive Investors

Mar 07, 2025

Mar 06, 2025

Lisata Therapeutics to Present at the Investival Showcase USA - The Manila Times

Mar 06, 2025

Mar 06, 2025

Can This Clinical-Stage Pharma Company Transform Solid Tumor Treatment? CEO Presents Next Month - StockTitan

Mar 06, 2025

Mar 05, 2025

Lisata Therapeutics and GATC Health Consummate First Step - GlobeNewswire

Mar 05, 2025

Mar 05, 2025

Market movers: General Motors, Moderna, CrowdStrike, Lisata... - Proactive Investors UK

Mar 05, 2025

Mar 05, 2025

Lisata Therapeutics And GATC Health Partner To Accelerate Drug Development Using AI Technology - Nasdaq

Mar 05, 2025

Mar 05, 2025

Lisata Therapeutics partners with GATC Health to advance AI-driven drug development - Proactive Investors UK

Mar 05, 2025

Mar 05, 2025

Can AI Revolutionize Lisata's Pancreatic Cancer Drug? New GATC Health Partnership Aims to Prove It - StockTitan

Mar 05, 2025

Mar 05, 2025

Neostem stock hits 52-week low at $2.15 amid market challenges - Investing.com Australia

Mar 05, 2025

Mar 03, 2025

Neostem stock hits 52-week low at $2.15 amid market challenges By Investing.com - Investing.com South Africa

Mar 03, 2025

Feb 28, 2025

Lisata Therapeutics’ Earnings Call: Progress Amid Challenges - TipRanks

Feb 28, 2025

Feb 28, 2025

Lisata Therapeutics Inc (LSTA) Q4 2024 Earnings Call Highlights: Promising Developments Amid Financial Challenges - GuruFocus.com

Feb 28, 2025

Feb 28, 2025

Lisata Therapeutics Inc (LSTA) Q4 2024 Earnings Call Highlights: Promising Developments Amid ... - Yahoo

Feb 28, 2025

Feb 28, 2025

Lisata Therapeutics Reports 2024 Financial Results and Updates - TipRanks

Feb 28, 2025

Feb 27, 2025

Earnings call transcript: Lisata Therapeutics Q4 2024 sees steady progress By Investing.com - Investing.com South Africa

Feb 27, 2025

Feb 27, 2025

Lisata Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 27, 2025

Feb 27, 2025

Earnings call transcript: Lisata Therapeutics Q4 2024 sees steady progress - Investing.com India

Feb 27, 2025

Feb 27, 2025

Lisata Therapeutics, Inc. (NASDAQ:LSTA) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 27, 2025

Feb 27, 2025

Lisata Therapeutics CEO: 2025 to be ‘data-rich’ as certepetide trials progress - Proactive Investors UK

Feb 27, 2025

Feb 27, 2025

Lisata Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update - GlobeNewswire

Feb 27, 2025